A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease

被引:33
|
作者
Patchett, Stephanie [1 ]
Lv, Zongyang [2 ]
Rut, Wioletta [3 ]
Bekes, Miklos [1 ,4 ]
Drag, Marcin [3 ]
Olsen, Shaun K. [2 ]
Huang, Tony T. [1 ]
机构
[1] NYU, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA
[3] Wroclaw Univ Sci & Technol, Dept Chem Biol & Bioimaging, Wyb Wyspianskiego 27, PL-50370 Wroclaw, Poland
[4] Arvinas Inc, 5 Sci Pk, New Haven, CT 06511 USA
来源
CELL REPORTS | 2021年 / 36卷 / 13期
关键词
RESPIRATORY-SYNDROME-CORONAVIRUS; RECOGNITION; DOMAIN; COV;
D O I
10.1016/j.celrep.2021.109754
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The SARS-CoV-2 papain-like protease (PLpro) is a target for antiviral drug development. It is essential for processing viral polyproteins for replication and functions in host immune evasion by cleaving ubiquitin (Ub) and ubiquitin-like protein (Ubl) conjugates. While highly conserved, SARS-CoV-2 and SARS-CoV PLpro have contrasting Ub/Ubl substrate preferences. Using a combination of structural analyses and functional assays, we identify a molecular sensor within the S1 Ub-binding site of PLpro that serves as a key determinant of substrate specificity. Variations within the S1 sensor specifically alter cleavage of Ub substrates but not of the Ubl interferon-stimulated gene 15 protein (ISG15). Significantly, a variant of concern associated with immune evasion carries a mutation in the S1 sensor that enhances PLpro activity on Ub substrates. Collectively, our data identify the S1 sensor region as a potential hotspot of variability that could alter host antiviral immune responses to newly emerging SARS-CoV-2 lineages.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] A Review of In Silico Research, SARS-CoV-2, and Neurodegeneration: Focus on Papain-Like Protease
    Rieder, Alessandra S.
    Deniz, Bruna F.
    Netto, Carlos Alexandre
    Wyse, Angela T. S.
    NEUROTOXICITY RESEARCH, 2022, 40 (05) : 1553 - 1569
  • [32] Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2
    Sanders, Brian C.
    Pokhrel, Suman
    Labbe, Audrey D.
    Mathews, Irimpan I.
    Cooper, Connor J.
    Davidson, Russell B.
    Phillips, Gwyndalyn
    Weiss, Kevin L.
    Zhang, Qiu
    O'Neill, Hugh
    Kaur, Manat
    Schmidt, Jurgen G.
    Reichard, Walter
    Surendranathan, Surekha
    Parvathareddy, Jyothi
    Phillips, Lexi
    Rainville, Christopher
    Sterner, David E.
    Kumaran, Desigan
    Andi, Babak
    Babnigg, Gyorgy
    Moriarty, Nigel W.
    Adams, Paul D.
    Joachimiak, Andrzej
    Hurst, Brett L.
    Kumar, Suresh
    Butt, Tauseef R.
    Jonsson, Colleen B.
    Ferrins, Lori
    Wakatsuki, Soichi
    Galanie, Stephanie
    Head, Martha S.
    Parks, Jerry M.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [33] Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease
    Li, Lingyu
    Ma, Liyan
    Hu, Yue
    Li, Xiaoxue
    Yu, Meng
    Shang, Hai
    Zou, Zhongmei
    PHYTOCHEMISTRY, 2022, 193
  • [34] Identification of Triazolopyrimidinyl Scaffold SARS-CoV-2 Papain-Like Protease (PLpro) Inhibitor
    Kralj, Sebastjan
    Jukic, Marko
    Bahun, Miha
    Kranjc, Luka
    Kolaric, Anja
    Hodoscek, Milan
    Ulrih, Natasa Poklar
    Bren, Urban
    PHARMACEUTICS, 2024, 16 (02)
  • [35] Structure-based design of SARS-CoV-2 papain-like protease inhibitors
    Jadhav, Prakash
    Huang, Bo
    Osipiuk, Jerzy
    Zhang, Xiaoming
    Tan, Haozhou
    Tesar, Christine
    Endres, Michael
    Jedrzejczak, Robert
    Tan, Bin
    Deng, Xufang
    Joachimiak, Andrzej
    Cai, Jianfeng
    Wang, Jun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 264
  • [36] Phthalimide derivatives as a new class of papain-like protease inhibitors in SARS-CoV-2
    Fischer, Thomas
    Frasson, David
    Sievers, Martin
    Riedl, Rainer
    ARCHIV DER PHARMAZIE, 2025, 358 (01)
  • [37] Genetically Encoded Fluorescent Sensors for SARS-CoV-2 Papain-like Protease PLpro
    Sokolinskaya, Elena L.
    Putlyaeva, Lidia, V
    Polinovskaya, Vasilisa S.
    Lukyanov, Konstantin A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [38] Fragment-Based Screen of SARS-CoV-2 Papain-like Protease (PLpro)
    Taylor, Ashley J.
    Amporndanai, Kangsa
    Rietz, Tyson A.
    Zhao, Bin
    Thiruvaipati, Anusha
    Wei, Qiangqiang
    South, Taylor M.
    Crow, Mackenzie M.
    Apakama, Chideraa
    Sensintaffar, John L.
    Phan, Jason
    Lee, Taekyu
    Fesik, Stephen W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (08): : 1351 - 1357
  • [39] Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
    Donghyuk Shin
    Rukmini Mukherjee
    Diana Grewe
    Denisa Bojkova
    Kheewoong Baek
    Anshu Bhattacharya
    Laura Schulz
    Marek Widera
    Ahmad Reza Mehdipour
    Georg Tascher
    Paul P. Geurink
    Alexander Wilhelm
    Gerbrand J. van der Heden van Noort
    Huib Ovaa
    Stefan Müller
    Klaus-Peter Knobeloch
    Krishnaraj Rajalingam
    Brenda A. Schulman
    Jindrich Cinatl
    Gerhard Hummer
    Sandra Ciesek
    Ivan Dikic
    Nature, 2020, 587 : 657 - 662
  • [40] Evaluating phytochemicals as SARS-CoV-2 papain-like protease inhibitors: a docking, ADMET and molecular dynamics investigation
    Wadanambi, Padmika Madushanka
    Mannapperuma, Uthpali
    Jayathilaka, Nimanthi
    CHEMICAL PAPERS, 2025,